These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

582 related articles for article (PubMed ID: 28538746)

  • 1. Medical management of hidradenitis suppurativa.
    Orenstein LA; Micheletti RG
    Semin Cutan Med Surg; 2017 Jun; 36(2):62-66. PubMed ID: 28538746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonal therapies for hidradenitis suppurativa: Review.
    Clark AK; Quinonez RL; Saric S; Sivamani RK
    Dermatol Online J; 2017 Nov; 23(10):. PubMed ID: 29469777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of severe recalcitrant hidradenitis suppurativa with adalimumab.
    Harde V; Mrowietz U
    J Dtsch Dermatol Ges; 2009 Feb; 7(2):139-41. PubMed ID: 19371236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-reported outcomes in hidradenitis suppurativa.
    Vellaichamy G; Braunberger TL; Jones JL; Peacock A; Nahhas AF; Hamzavi IH
    G Ital Dermatol Venereol; 2019 Apr; 154(2):137-147. PubMed ID: 30375207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical management and wound care approaches for hidradenitis suppurativa.
    Antia C; Alavi A; Alikhan A
    Semin Cutan Med Surg; 2017 Jun; 36(2):58-61. PubMed ID: 28538745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience of the use of adalimumab in the management of hidradenitis suppurativa. Comparison of response rates with Crohn disease.
    Moyano B; Clemente A; Marín-Jiménez I; Martorell A
    Actas Dermosifiliogr; 2016 Sep; 107 Suppl 2():43-50. PubMed ID: 28081769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigational drugs in clinical trials for Hidradenitis Suppurativa.
    Theut Riis P; Thorlacius LR; Jemec GB
    Expert Opin Investig Drugs; 2018 Jan; 27(1):43-53. PubMed ID: 29188733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of hidradenitis suppurativa.
    Drug Ther Bull; 2016 Sep; 54(9):102-5. PubMed ID: 27585997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective modified conservative tissue preserving protocol to treat stage I axillary hidradenitis suppurativa: a prospective cohort study of 627 patients with five years follow-up.
    Shirah BH; Shirah HA
    J Dermatolog Treat; 2017 Aug; 28(5):458-463. PubMed ID: 27981857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is There a Role for Antiandrogen Therapy for Hidradenitis Suppurativa? A Systematic Review of Published Data.
    Nikolakis G; Kyrgidis A; Zouboulis CC
    Am J Clin Dermatol; 2019 Aug; 20(4):503-513. PubMed ID: 31073704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hidradenitis suppurativa (acne inversa): management of a recalcitrant disease.
    Lam J; Krakowski AC; Friedlander SF
    Pediatr Dermatol; 2007; 24(5):465-73. PubMed ID: 17958790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted treatments for hidradenitis suppurativa: a review of the current literature and ongoing clinical trials.
    Maarouf M; Clark AK; Lee DE; Shi VY
    J Dermatolog Treat; 2018 Aug; 29(5):441-449. PubMed ID: 29098911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two diseases one remedy? Systemic amyloidosis secondary to hidradenitis suppurativa: Treatment with infliximab.
    Özer İ; Karaçin C; Adışen E; Güz G; Ali Gürer M
    Dermatol Ther; 2017 Mar; 30(2):. PubMed ID: 27862787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience with adalimumab biosimilar imraldi in hidradenitis suppurativa.
    Ricceri F; Rosi E; Di Cesare A; Pescitelli L; Fastame MT; Prignano F
    Dermatol Ther; 2020 Nov; 33(6):e14387. PubMed ID: 33030281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of 5-aminolevulinic acid photodynamic therapy in the treatment of hidradenitis suppurativa: a report of 5 cases.
    Andino Navarrete R; Hasson Nisis A; Parra Cares J
    Actas Dermosifiliogr; 2014; 105(6):614-7. PubMed ID: 24472519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologic Treatment for Hidradenitis Suppurativa.
    Flood KS; Porter ML; Kimball AB
    Am J Clin Dermatol; 2019 Oct; 20(5):625-638. PubMed ID: 31140067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of interleukin-17 in the pathogenesis of hidradenitis suppurativa.
    Yao Y; Thomsen SF
    Dermatol Online J; 2017 Jul; 23(7):. PubMed ID: 29469692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hidradenitis Suppurativa: A Guide for the Practicing Physician.
    Woodruff CM; Charlie AM; Leslie KS
    Mayo Clin Proc; 2015 Dec; 90(12):1679-93. PubMed ID: 26653298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New treatment strategies for hidradenitis suppurativa.
    Andersen R; Jemec GB
    Drugs Today (Barc); 2016 Aug; 52(8):439-451. PubMed ID: 27722212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on Hidradenitis Suppurative (Part II): Treatment.
    Martorell A; García FJ; Jiménez-Gallo D; Pascual JC; Pereyra-Rodríguez J; Salgado L; Villarrasa E
    Actas Dermosifiliogr; 2015 Nov; 106(9):716-24. PubMed ID: 26277040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.